E-mail : ceo@quality-ebike.com
Tirzepatide CAS 2023788-19-2
Tirzepatide CAS 2023788-19-2
If you couldn't find the product you want in our store, maybe we haven't uploaded the complete product, please feel free to contact us through various ways; if you want to customize and process the product you want, please feel free to contact us for more details too.
Tirzepatide CAS 2023788-19-2
Specification
TR5 5mg*10vials
TR10 10mg*10vials
TR15 15mg*10vials
TR20 20mg*10vials
TR30 30mg*10vials
TR40 40mg*10vials
TR45 45mg*10vials
TR50 50mg*10vials
TR60 60mg *10vials
Name Tirzepatide
Synonyms Tirzepatide; GIP\GLP-1; Tirzepatide(LY3298176); Trizepatide; Gip\GLP-1TirzepatideLy3298176 Peptide; Tilposide; Tirzepatide(GLP-1); terzapitide
CAS No. 2023788-19-2
Storage conditions Store at -20°C
Tirzepatide is a new type of glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP, also known as: gastric inhibitory polypeptide) dual receptor agonist, administered once a week. GLP-1 and GIP are both incretins, which are polypeptides secreted by the gastrointestinal mucosa of the human body. The former can bind to receptors on pancreatic islet cells and stimulate insulin secretion, thereby producing a hypoglycemic effect, and can also delay gastric emptying and suppress appetite, thereby controlling weight; while the latter has the functions of inhibiting gastric acid and pepsin secretion, stimulating insulin release, inhibiting gastric motility and emptying, and can supplement the effect of GLP-1 receptor agonists. Tirzepatide integrates the effects of two insulinotropic agents into a single molecule, representing a new class of drugs for the treatment of type 2 diabetes.
- Name
- Phone
- Corporate name
- Address
- Leaving Message*
